Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
102.50
-1.50 (-1.44%)
At close: Jan 22, 2026
-22.76%
Market Cap23.68B
Revenue (ttm)11.58B
Net Income (ttm)570.05M
Shares Out231.00M
EPS (ttm)2.47
PE Ratio41.54
Forward PEn/a
Dividend2.10 (2.02%)
Ex-Dividend DateNov 17, 2025
Volume217,059
Average Volume163,821
Open105.00
Previous Close104.00
Day's Range102.00 - 105.00
52-Week Range92.40 - 147.50
Beta-0.64
RSI43.03
Earnings DateJan 28, 2026

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointesti... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 4,162
Stock Exchange Dhaka Stock Exchange
Ticker Symbol BEACONPHAR
Full Company Profile

Financial Performance

In 2024, Beacon Pharmaceuticals's revenue was 10.70 billion, an increase of 25.76% compared to the previous year's 8.51 billion. Earnings were 521.01 million, an increase of 2.19%.

Financial Statements